MICA gene and ankylosing spondylitis: Linkage analysis via a transmembrane-encoded triplet repeat polymorphism

Tissue Antigens

Volumn 49, Issue 5, 1997, Pages 503-507

  Goto, K ^a,b   Ota, M ^c   Ohno, S ^a   Mizuki, N ^a,b   Ando, H ^d   Katsuyama, Y ^c   Maksymowych, W P ^e   Kimura, M ^b   Bahram, S ^f   Inoko, H ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Japanese Red Cross Society   (Japan)

^e UNIVERSITY OF ALBERTA   (Canada)

^f BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

Author keywords

Ankylosing spondylitis; MICA gene; Transmembrane region; Triplet repeat polymorphism

Indexed keywords

ANKYLOSING SPONDYLITIS; ARTICLE; CODON; DNA POLYMORPHISM; GENETIC MARKER; HAPLOTYPE; HISTOCOMPATIBILITY COMPLEX; HISTOCOMPATIBILITY GENE; HUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL;

EID: 8244219686     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1997.tb02786.x     Document Type: Article

References (15)

1. Calin A. Spondyloarthropathies. In: Kelley WN, Harris ED, Ruddy S, ed. Texthook of rheumatology. 3rd edn. Philadelphia: WB Saunders, 1989: 1023-1039.
2. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973: 288: 704-706.
3. Brewerton DA, Caffrey M, Hart FD, James DCO, Nicholls A, Sturrock RD. Ankylosing spondylitis and HLA-B27. Lancet 1973: 1: 904-907.
4. Hammer RE, Maika DS, Richardson AJ, Tang PJ, Taurog DJ. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2m: an animal model of HLA-B27-associated human disorders. Cell 1990: 63: 1099-1112.
5. Taurog JD, Maika SD, Simmons WA, Breban M, Hammer RE. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J Immunol 1993: 150: 4168-4178.
6. Coppin HL, McDevitt HO. Absence of polymorphism between HLA-B27 genomic exon sequences isolated from normal donors and ankylosing spondylitis patients. J Immunol 1986: 137: 2168-2172.
7. Carlos LL, Severino GR, Mercedes P et al. Characterization of B27 haplotypes by oligotyping and genomic sequencing in the Mexican Mestizo population with ankylosing spondylitis. Hum Immunol 1995: 43: 174-180.
8. Breur VBS, Dekker SAJ, Ivanyi P. Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of various B27 molecules. Ann Rheum Dis 1987: 46: 353-356.
9. Lopez LC, Sujirachato K, Mehra NK, et al. HLA-B27 subtypes in Asia patients with ankylosing spondylitis. Tissue Antigens 1995: 45: 169-176.
10. Bedendo A, Glorioso S, Venturi PC et al. A family study of ankylosing spondylitis. Rheumatol Int 1984: 5: 29-32.
11. Bahram S, Bresnahan M, Geraghty DE, Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci U S A 1994: 91: 6259-6263.
12. Bahram S, Spies T. The MIC gene family. Res Immunol 1996: 147: 328-333.
13. Fodil N, Laloux L, Wanner V et al. Allelic repertoire of the human MHC class I MICA gene. Immunogenetics 1996: 44: 351-357.
14. Van der Iinden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984: 27: 361-368.
15. Gustincich S, Manfioletti G, Del Sal G, Schneider C. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 1991: 11: 298-302.